https://nl.marketscreener.com/koers/aandeel/TEMPEST-THERAPEUTICS-INC-124221532/nieuws/Tempest-Therapeutics-Inc-presenteert-fase-1-monotherapie-en-combinatiegegevens-op-ASCO-voor-TPST-43955931/?utm_source=telegram&utm_medium=social&utm_campaign=share